Nebula Research & Development LLC Ani Pharmaceuticals Inc Transaction History
Nebula Research & Development LLC
- $464 Billion
- Q1 2024
A detailed history of Nebula Research & Development LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 10,639 shares of ANIP stock, worth $677,491. This represents 0.16% of its overall portfolio holdings.
Number of Shares
10,639Holding current value
$677,491% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding ANIP
# of Institutions
206Shares Held
14MCall Options Held
26.7KPut Options Held
237K-
Black Rock Inc. New York, NY2.53MShares$161 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$83.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY959KShares$61 Million2.26% of portfolio
-
Deep Track Capital, LP Greenwich, CT822KShares$52.3 Million1.88% of portfolio
-
Dimensional Fund Advisors LP Austin, TX609KShares$38.8 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.11B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...